ALX ONCOLOGY HOLDINGS INC Shares Outstanding (Cover Page)
ALX ONCOLOGY HOLDINGS INC (ALXO) had Shares Outstanding (Cover Page) of 138.28 million shares as of 2026-07-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-30: Entity Common Stock, Shares Outstanding 138.28M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 134.56M shares.
- 2026-03-02: Entity Common Stock, Shares Outstanding 131.61M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 54.22M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 138.28M shares 10-Q · filed 2026-08-06 |
| 2026-05-01 | 134.56M shares 10-Q · filed 2026-05-08 |
| 2026-03-02 | 131.61M shares 10-K · filed 2026-03-09 |
| 2025-10-31 | 54.22M shares 10-Q · filed 2025-11-07 |
| 2025-08-05 | 53.55M shares 10-Q · filed 2025-08-12 |
| 2025-05-01 | 53.44M shares 10-Q · filed 2025-05-08 |
| 2025-02-27 | 53.38M shares 10-K · filed 2025-03-06 |
| 2024-10-31 | 52.74M shares 10-Q · filed 2024-11-07 |
| 2024-08-01 | 52.67M shares 10-Q · filed 2024-08-12 |
| 2024-05-02 | 52.10M shares 10-Q · filed 2024-05-09 |
| 2024-02-29 | 50.15M shares 10-K · filed 2024-03-07 |
| 2023-11-06 | 49.82M shares 10-Q · filed 2023-11-13 |
| 2023-08-03 | 41.15M shares 10-Q · filed 2023-08-10 |
| 2023-05-04 | 40.87M shares 10-Q · filed 2023-05-11 |
| 2023-03-02 | 40.86M shares 10-K · filed 2023-03-09 |
| 2022-11-01 | 40.76M shares 10-Q · filed 2022-11-08 |
| 2022-08-02 | 40.75M shares 10-Q · filed 2022-08-08 |
| 2022-05-02 | 40.68M shares 10-Q · filed 2022-05-09 |
| 2022-02-22 | 40.63M shares 10-K · filed 2022-02-28 |
| 2021-11-08 | 40.50M shares 10-Q · filed 2021-11-12 |
| 2021-08-06 | 40.34M shares 10-Q · filed 2021-08-12 |
| 2021-05-11 | 40.23M shares 10-Q · filed 2021-05-17 |
| 2021-03-12 | 40.13M shares 10-K · filed 2021-03-18 |
| 2020-11-06 | 37.11M shares 10-Q · filed 2020-11-12 |
| 2020-08-21 | 36.97M shares 10-Q · filed 2020-08-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |